» Articles » PMID: 11431739

Toll-like Receptor 4 is Involved in the Mechanism of Early Alcohol-induced Liver Injury in Mice

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2001 Jun 30
PMID 11431739
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic alcohol administration increases gut-derived endotoxin in the portal blood, which activates Kupffer cells and causes liver injury. Mice (C3H/HeJ) with mutations in toll-like receptor 4 (TLR4) are hyporesponsive to endotoxin. To test the hypothesis that TLR4 is involved in early alcohol-induced liver injury, the long-term intragastric ethanol feeding protocol developed by Tsukamoto and French for rats was adapted to mice. Animals with nonfunctional TLR4 and wild-type mice (C3H/HeOuJ) were compared. Two-month-old female mice were fed a high-fat liquid diet with either ethanol or isocaloric maltose-dextrin as control continuously for 4 weeks. There was no difference in mean urine alcohol concentrations between the groups. Dietary alcohol significantly increased liver-to-body weight ratios and serum alanine transaminase (ALT) levels in wild-type mice (109 +/- 18 U/L) over high-fat controls (40 +/- 3 U/L), effects that were blunted significantly in mice with a mutation of TLR4 (55 +/- 9 U/L). While no significant pathologic changes were observed in high-fat controls, dietary ethanol caused steatosis, mild inflammation, and focal necrosis in wild-type animals (pathology score = 5.2 +/- 1.2). These pathologic changes were significantly lower in TLR4-deficient mice fed ethanol (score = 2.0 +/- 1.3). Endotoxin levels in the portal vein were increased significantly after 4 weeks in both groups fed ethanol. Moreover, ethanol increased tumor necrosis factor alpha (TNF-alpha) mRNA expression in wild-type, but not in TLR4-deficient, mice. These data are consistent with the hypothesis that Kupffer cell activation by endotoxin via TLR4 is involved in early alcohol-induced liver injury.

Citing Articles

BRISC inactivation alleviates alcohol-induced liver injury in mice.

Wang T, Zhang W, Liu X, Liu K, Ren G, Xiang S Sci Rep. 2025; 15(1):5154.

PMID: 39934386 PMC: 11814121. DOI: 10.1038/s41598-025-89796-2.


Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease.

Li W, Gao W, Yan S, Yang L, Zhu Q, Chu H Biomedicines. 2025; 13(1).

PMID: 39857657 PMC: 11761646. DOI: 10.3390/biomedicines13010074.


Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.

Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R Antioxidants (Basel). 2025; 14(1).

PMID: 39857390 PMC: 11759774. DOI: 10.3390/antiox14010056.


Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer.

Feng Y, Chen C, Shao A, Wu L, Hu H, Zhang T Acta Pharm Sin B. 2025; 14(12):5091-5105.

PMID: 39807338 PMC: 11725142. DOI: 10.1016/j.apsb.2024.09.008.


Lactobacillus helveticus attenuates alcoholic liver injury via regulation of gut microecology in mice.

Lv J, Lang G, Wang Q, Zhao W, Shi D, Zhou Z Microb Biotechnol. 2024; 17(10):e70016.

PMID: 39431804 PMC: 11492535. DOI: 10.1111/1751-7915.70016.